PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21424108-0	2011	Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.	Trinitrobenzenesulfonic Acid	75-79	interleukin 23, alpha subunit p19	Mus musculus	16-21	
30765845-3	2019	In this report, we found that mTOR inhibitor rapamycin or mTOR deletion in CX3Cr1+ mononuclear phagocytes inhibits expression of interleukin (IL)-23, accompanied by reduced intestinal production of IL-22 and ameliorated fibrosis in the TNBS-induced fibrosis mouse model.	Trinitrobenzenesulfonic Acid	236-240	interleukin 23, alpha subunit p19	Mus musculus	129-148	
29545894-6	2018	In TNBS mice receiving AdTGF-2, the increase in IFN-gamma, tumor necrosis factor-alpha, IL-6, IL-17 and IL-23 was significantly prevented by dexamethasone treatment.	Trinitrobenzenesulfonic Acid	3-7	interleukin 23, alpha subunit p19	Mus musculus	104-109	
21424108-8	2011	After administrations of TNBS, vaccinated mice had significantly less body weight loss and a significant decrease of inflammatory scores, collagen deposition and expression of p40, IL-12, IL-23, IL-17, TNF, iNOS and Bcl-2 in colon tissues, compared with carrier and saline groups.	Trinitrobenzenesulfonic Acid	25-29	interleukin 23, alpha subunit p19	Mus musculus	188-193